Showing results (121-130 of 148) with videos related to
Sort By:
Pageof 15
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|January 6, 2023
Impact of Early Treatment with Intravenous High-Dose Methylprednisolone for Ocular Myasthenia GravisAkiyuki Uzawa, Shigeaki Suzuki, Satoshi Kuwabara, et al.Journal of Neurology, Neurosurgery, and Psychiatry|January 24, 2023
Effectiveness of early cycles of fast-acting treatment in generalised myasthenia gravisAkiyuki Uzawa, Shigeaki Suzuki, Satoshi Kuwabara, et al.Journal of Neuroimmunology|November 12, 2023
Clinical features and outcomes of patients with muscle-specific kinase antibody-positive myasthenia gravis in JapanManato Yasuda, Akiyuki Uzawa, Satoshi Kuwabara, et al.BMC Neurology|April 25, 2024
Taste disorders and alopecia in myasthenia gravisAkiyuki Uzawa, Shigeaki Suzuki, Satoshi Kuwabara, et al.Plos One|August 14, 2025
Predicting achievement of clinical goals using machine learning in myasthenia gravisHiroyuki Akamine, Akiyuki Uzawa, Satoshi Kuwabara, et al.Internal Medicine (Tokyo, Japan)|June 11, 2025
Association between Myasthenia Gravis and SmokingHiroyuki Akamine, Akiyuki Uzawa, Satoshi Kuwabara, et al.Neurology|February 28, 2014
A Kir3.4 mutation causes Andersen-Tawil syndrome by an inhibitory effect on Kir2.1Yosuke Kokunai, Tomohiko Nakata, Mitsuru Furuta, et al.Journal of Human Genetics|August 20, 2024
Hydrops fetalis due to loss of function of hNav1.4 channel via compound heterozygous variantsTomoya Kubota, Miho Nagata, Kazuko Takagi, et al.Science Advances|November 22, 2023
RGMa collapses the neuronal actin barrier against disease-implicated protein and exacerbates ALSMikito Shimizu, Naoyuki Shiraishi, Satoru Tada, et al.Research Involvement and Engagement|February 2, 2021
The practice of active patient involvement in rare disease research using ICT: experiences and lessons from the RUDY JAPAN projectNao Hamakawa, Atsushi Kogetsu, Moeko Isono, et al.Pageof 15